Despite announcing a broad pivot to siRNA earlier this year, Sarepta is following through with an investigational gene ...
This is a sponsored article brought to you by MBZUAI. If you’ve ever tried to guess how a cell will change shape after a drug ...
Receiving a platform technology designation from the FDA is a tremendous milestone for our development team and Krystal, both as recognition of the reproducibility and scalability of our HSV-1 gene ...
Researchers have achieved the first demonstration in mice of using gene therapy to reverse hallmark symptoms of ...
Rapid advances in viral vectors, advanced plasmid DNA and oncology drive new expansion in global markets.Austin, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Gene Therapy Starting Materials Market Size & Growth ...
TipRanks on MSN
Circio Converts Bonds to Shares, Boosting Market Confidence
Targovax ASA ( ($GB:0RIS) ) has shared an announcement. Circio Holding ASA announced the conversion of all outstanding convertible bonds held by ...
BT-001 in combination with pembrolizumab is well tolerated and shows sustained antitumoral activity in both injected and non-injected lesionsData ...
An mRNA cancer vaccine carries its own immune booster and lights up when it starts working, showing treatment success in mice ...
The host cell system is a critical determinant of recombinant protein quality and yield, with direct influence on protein ...
Individual retinal ganglion cells are singularly activated in the living primate retina via an adaptive optics scanning light ophthalmoscope.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback